pharma news, views and analysis - pharmaphorum.com

Trending

in News
Mallinckrodt proposes $1.6bn deal to settle opioid litigation
February 26, 2020 Share
X
Mallinckrodt proposes $1.6bn deal to settle opioid litigation
https://pharmaphorum.com/news/mallinckrodt-proposes-1-6bn-deal-to-settle-opioid-litigation/
in News
Diversity initiative DICE launches to tackle conference inclusion
February 24, 2020 Share
X
Diversity initiative DICE launches to tackle conference inclusion
https://pharmaphorum.com/news/marketing-conference-diversity-initiative-dice/

Latest News

performance-io appoints Amy de la Force as executive creative director

performance-io appoints Amy de la Force as executive creative director

London-based health-tech performance marketing agency performance-io has expanded, forming a new creative department and recruiting Amy de la

X

performance-io appoints Amy de la Force as executive creative director

https://pharmaphorum.com/news/performance-io-amy-de-la-force/

Cello Health Insight brings Breaking Blue into the fold

Cello Health Insight brings Breaking Blue into the fold

Cello Health has merged its global tech and consumer research business Breaking Blue Research with its Cello Health

X

Cello Health Insight brings Breaking Blue into the fold

https://pharmaphorum.com/news/cello-health-insight-breaking-blue-research/

Blockbusters in waiting: drug launches to watch in 2020

Blockbusters in waiting: drug launches to watch in 2020

New drugs for breast cancer, lymphoma, multiple sclerosis and migraine are among new product launches this year that

X

Blockbusters in waiting: drug launches to watch in 2020

https://pharmaphorum.com/news/blockbusters-in-waiting-drug-launches-to-watch-in-2020/

Views & Analysis

Customer experience in pharma: Getting the journey right

Customer experience in pharma: Getting the journey right

As part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma,

X

Customer experience in pharma: Getting the journey right

https://pharmaphorum.com/views-analysis-sales-marketing/customer-experience-in-pharma-getting-the-journey-right/

UK leaders: Takeda’s Jon Neal

UK leaders: Takeda’s Jon Neal

In the first of a new series where we talk to GMs of UK pharma divisions, managing director

X

UK leaders: Takeda’s Jon Neal

https://pharmaphorum.com/views-analysis-market-access/uk-leaders-takeda-jon-neal/

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

Shares in Biogen jumped last week after the company successfully defended its blockbuster MS drug Tecfidera from a

X

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

https://pharmaphorum.com/views-analysis-sales-marketing/tecfideras-patent-pyrrhic-victory-biogen/

Debates & Insights

How to optimise pharma’s digital HCP engagement

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if

X

How to optimise pharma’s digital HCP engagement

https://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/

Ensuring delivery of healthcare professional education

Ensuring delivery of healthcare professional education

Pharma companies always need to know they can get the right information to the right people at the

X

Ensuring delivery of healthcare professional education

https://pharmaphorum.com/debates-insight-sales-marketing/ensuring-delivery-of-healthcare-professional-education/

Good data supports pharma sales reps to drive lead generation

Good data supports pharma sales reps to drive lead generation

Allow pharma sales reps to focus on the job in hand by making sure they have access to

X

Good data supports pharma sales reps to drive lead generation

https://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/

Partner Content

Key Questions To Boost Your KOL Management– Part 1/8: KOL Identification

Key Questions To Boost Your KOL Management– Part 1/8: KOL Identification

Introduction to KOL identification and it’s value

X

Key Questions To Boost Your KOL Management– Part 1/8: KOL Identification

https://pharmaphorum.com/partner-content/key-questions-to-boost-your-kol-management-part-1-8-kol-identification/

6th Annual Next Generation Sequencing USA Congress

6th Annual Next Generation Sequencing USA Congress

2 days, 350+ end users, 80+ case studies

X

6th Annual Next Generation Sequencing USA Congress

https://pharmaphorum.com/partner-content/6th-annual-next-generation-sequencing-usa-congress/

6th Annual Single Cell Analysis USA Congress

6th Annual Single Cell Analysis USA Congress

2 days, 350+ end users, 80+ case studies

X

6th Annual Single Cell Analysis USA Congress

https://pharmaphorum.com/partner-content/6th-annual-single-cell-analysis-usa-congress/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com